Hematogones in patients with acute myeloid leukaemia: Prognostic value and correlation with minimal residual disease

• Rita Tavarozzi,
• Enrica Manzato,
• Riccardo Morganti,
• Paola Sammuri,
• Giulia Tarrini,
• Federica Ricci,
• Giordana Mattana,
• Sara Galimberti,
• Mario Petrini,
• Giovanni Carulli

Affiliations

Rita Tavarozzi

SC Hematology, AO N SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy; Corresponding author. SC Hematology, AON SS Antonio e Biagio e Cesare Arrigo, via Venezia 16, 15121, Alessandria, Italy.

Enrica Manzato

Sant'Anna School of Advanced Studies, Pisa, Italy; Department of Clinical and Experimental Medicine, Section of Haematology, University of Pisa, Pisa, Italy

Riccardo Morganti

Statistic Analysis Unit, Pisa University Hospital, Pisa, Italy

Paola Sammuri

Department of Clinical and Experimental Medicine, Section of Haematology, University of Pisa, Pisa, Italy

Giulia Tarrini

Laboratory of Clinical Chemical Analysis, Department of Laboratory Medicine, San Giovanni di Dio Hospital, Florence

Federica Ricci

Department of Clinical and Experimental Medicine, Section of Haematology, University of Pisa, Pisa, Italy

Giordana Mattana

Specialization School in Clinical Pathology, University of Pisa, Pisa, Italy

Sara Galimberti

Department of Clinical and Experimental Medicine, Section of Haematology, University of Pisa, Pisa, Italy

Mario Petrini

Department of Clinical and Experimental Medicine, Section of Haematology, University of Pisa, Pisa, Italy

Giovanni Carulli

Department of Clinical and Experimental Medicine, Section of Haematology, University of Pisa, Pisa, Italy